×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Scott Bizily

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerSep 16, 2024Sale$16.335008,1656,781Sep 18, 2024, 05:46 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerSep 16, 2024Option/RSU Exercise$6.495003,2457,281Sep 18, 2024, 05:46 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerAug 19, 2024Option/RSU Exercise$6.495003,2457,281Aug 21, 2024, 04:28 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerAug 19, 2024Sale$15.005007,5006,781Aug 21, 2024, 04:28 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJul 16, 2024Option/RSU Exercise$7.601,75013,2958,531Jul 18, 2024, 08:22 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJul 16, 2024Sale$27.111,75047,4436,781Jul 18, 2024, 08:22 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJul 11, 2024Option/RSU Exercise$15.781,99631,4978,777Jul 15, 2024, 06:13 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJul 11, 2024Sale$25.001,99649,9006,781Jul 15, 2024, 06:13 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJul 01, 2024Option/RSU Exercise$7.554,24832,0895,985Jul 03, 2024, 05:11 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJul 01, 2024Sale$21.364,24890,7581,737Jul 03, 2024, 05:11 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJun 17, 2024Option/RSU Exercise$7.601,75013,2953,487Jun 20, 2024, 04:59 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerJun 17, 2024Sale$23.711,75041,4941,737Jun 20, 2024, 04:59 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerMay 16, 2024Option/RSU Exercise$7.601,75013,2953,487May 20, 2024, 08:35 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerMay 16, 2024Sale$25.451,75044,5412,204May 20, 2024, 08:35 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerApr 16, 2024Option/RSU Exercise$7.601,75013,2953,487Apr 18, 2024, 08:48 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerApr 16, 2024Sale$25.741,75045,0451,737Apr 18, 2024, 08:48 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerApr 01, 2024Sale$31.788,153259,1021,737Apr 03, 2024, 07:18 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerApr 01, 2024Option/RSU Exercise$12.548,153102,2249,890Apr 03, 2024, 07:18 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerMar 27, 2024Option/RSU Exercise$25.985,833151,5417,570Mar 29, 2024, 04:52 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerMar 27, 2024Sale$35.045,833204,4101,737Mar 29, 2024, 04:52 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerMar 18, 2024Option/RSU Exercise$7.601,75013,2953,487Mar 20, 2024, 04:40 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerMar 18, 2024Sale$31.271,75054,7231,737Mar 20, 2024, 04:40 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerFeb 27, 2024Option/RSU Exercise$20.241,90938,6383,646Feb 29, 2024, 06:01 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerFeb 27, 2024Sale$30.001,90957,2701,737Feb 29, 2024, 06:01 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerFeb 16, 2024Option/RSU Exercise$7.601,75013,2953,487Feb 21, 2024, 05:41 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerFeb 16, 2024Sale$27.671,75048,4231,737Feb 21, 2024, 05:41 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerFeb 08, 2024Option/RSU Exercise$10.186,24463,5864,653Feb 12, 2024, 09:04 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal OfficerFeb 08, 2024Sale$27.506,244171,7101,737Feb 12, 2024, 09:04 PM
FMDT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerJun 08, 2023Option/RSU Exercise$8.043,75030,1505,487Jun 12, 2023, 06:23 PM
FMDT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerJun 08, 2023Sale$20.853,75078,1881,737Jun 12, 2023, 06:23 PM
FMDT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerJun 01, 2023Option/RSU Exercise$6.491,87512,1693,984Jun 06, 2023, 07:23 PM
FMDT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerJun 01, 2023Sale$18.312,24741,1431,737Jun 06, 2023, 07:23 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerApr 21, 2023Sale$20.003,75075,0002,109Apr 25, 2023, 06:44 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerApr 21, 2023Option/RSU Exercise$8.043,75030,1505,859Apr 25, 2023, 06:44 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerMar 01, 2023Option/RSU Exercise$6.491,87512,1694,357Mar 03, 2023, 06:16 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerMar 01, 2023Sale$19.302,24843,3862,109Mar 03, 2023, 06:16 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerDec 01, 2022Option/RSU Exercise$7.525,62542,3196,607Dec 05, 2022, 05:33 PM
FDMT4D Molecular Therapeutics, Inc.Scott BizilyChief Legal and HR OfficerDec 01, 2022Sale$22.796,000136,7255,607Dec 05, 2022, 05:33 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe